Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ublituximab (LFB-R603; TG-1101; TGTX-1101), a next-generation, type 1 chimeric monoclonal antibody, specifically targets a unique epitope on the CD20 antigen, demonstrating anticancer effects [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Ublituximab (LFB-R603; TG-1101; TGTX-1101), a next-generation, type 1 chimeric monoclonal antibody, specifically targets a unique epitope on the CD20 antigen, demonstrating anticancer effects [1]. |
Molecular Weight | N/A |
CAS No. | 1174014-05-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ublituximab 1174014-05-1 inhibitor inhibit